Showing 1 - 3 of 3
The accessibility of medicinal cannabis took another step forward on 22 March when Scotland’s first medicinal cannabis clinic was given authority to open by the regulator. Against this background, we consider the state of play of medicinal cannabis in the UK since its legalisation in 2018 and explore some potential product liability implications that may arise.
2020 was a challenging year globally. However, the start of 2021 has welcomed the rapid roll out of the breakthrough COVID-19 vaccines in the UK, a ray of hope for a way out of the pandemic. Over 20 million people in the UK have already been given vaccine doses, with the hope that the majority of the UK adult population will be vaccinated by the end of 2021.
Case review 30/03/2020
The Court of Appeal in this case provided guidance on what to consider when deciding on the rate of interest constructive trustees should pay in an equitable compensation claim, which arose out of a breach of fiduciary duty.